11 Recruiting Myelofibrosis Phase 2 Clinical Trials
Active phase 2 studies for myelofibrosis enrolling across the USA. Verify eligibility and contact site coordinators.
All Myelofibrosis studiesPhase 2 Studies for Myelofibrosis
A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis
📍 The Oncology Institute of Hope and Innovation — Pasadena, California
View Study & Checklist ➔A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
📍 Local Institution - 0069 — Newport Beach, California
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
📍 MD Andersson Cancer Hospital — Houston, Texas
View Study & Checklist ➔A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
📍 Memorial Sloan Kettering Monmouth — Middletown, New Jersey
View Study & Checklist ➔Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
📍 The University of Kansas Cancer Center-Westwood — Westwood, Kansas
View Study & Checklist ➔Revumenib in Patients With Myelofibrosis
📍 Icahn School of Medicine at the Mount Sinai Hospital — New York, New York
View Study & Checklist ➔A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
📍 Massachusetts General Hospital (Data Collection Only) — Boston, Massachusetts
View Study & Checklist ➔Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
View Study & Checklist ➔A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
📍 City of Hope - Duarte Main Site — Duarte, California
View Study & Checklist ➔Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔